Mineralys Therapeutics, Inc.
MLYS
43 insider filings · Latest: Sep 30, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Jun 15 8:58 PM | Rodman David Malcom | Proposed Sale | 9,890 | $23.81 | $235.5K | — | View → |
| Jun 12, 2026 | Jun 12 10:04 PM | David Malcom RodmanChief Medical Officer | Sale | 6,349 | $23.93 | $151.9K | 63,443(D) | View → |
| Jun 10, 2026 | Jun 12 10:04 PM | David Malcom RodmanChief Medical Officer | Sale | 2,170 | $25.00 | $54.3K | 63,443(D) | View → |
| Jun 12, 2026 | Jun 12 8:17 PM | Rodman David Malcom | Proposed Sale | 6,349 | $23.93 | $151.9K | — | View → |
| Jun 10, 2026 | Jun 10 8:11 PM | Rodman David Malcom | Proposed Sale | 2,170 | $25.00 | $54.3K | — | View → |
| May 18, 2026 | May 19 11:15 PM | David Malcom RodmanChief Medical Officer | Sale | 417 | $27.55 | $11.5K | 63,443(D) | View → |
| May 18, 2026 | May 18 8:10 PM | Rodman David Malcom | Proposed Sale | 417 | $27.55 | $11.5K | — | View → |
| May 13, 2026 | May 14 1:42 AM | David Malcom RodmanChief Medical Officer | Sale | 14,056 | $28.58 | $401.8K | 63,443(D) | View → |
| May 12, 2026 | May 14 1:42 AM | David Malcom RodmanChief Medical Officer | Sale | 6,348 | $29.36 | $186.3K | 69,792(D) | View → |
| May 11, 2026 | May 14 1:42 AM | David Malcom RodmanChief Medical Officer | Sale | 2,171 | $29.71 | $64.5K | 69,792(D) | View → |
| May 13, 2026 | May 13 8:11 PM | Rodman David Malcom | Proposed Sale | 14,056 | $28.58 | $401.8K | — | View → |
| May 12, 2026 | May 12 9:05 PM | Rodman David Malcom | Proposed Sale | 6,348 | $29.36 | $186.3K | — | View → |
| May 11, 2026 | May 11 8:27 PM | Rodman David Malcom | Proposed Sale | 2,171 | $29.71 | $64.5K | — | View → |
| Apr 17, 2026 | Apr 21 10:59 PM | David Malcom RodmanChief Medical Officer | Sale | 416 | $31.33 | $13.0K | 69,792(D) | View → |
| Apr 17, 2026 | Apr 17 8:17 PM | Rodman David Malcom | Proposed Sale | 416 | $31.33 | $13.0K | — | View → |
| Apr 15, 2026 | Apr 16 1:45 AM | David Malcom RodmanChief Medical Officer | Sale | 6,348 | $27.66 | $175.6K | 69,792(D) | View → |
| Apr 13, 2026 | Apr 16 1:45 AM | David Malcom RodmanChief Medical Officer | Sale | 14,058 | $26.54 | $373.1K | 76,140(D) | View → |
| Apr 13, 2026 | Apr 16 1:45 AM | Jon CongletonDirector, Chief Executive Officer | Sale | 15,730 | $26.83 | $422.0K | 689,321(D) | View → |
| Apr 15, 2026 | Apr 15 8:21 PM | Rodman David Malcom | Proposed Sale | 6,348 | $27.66 | $175.6K | — | View → |
| Apr 9, 2026 | Apr 14 1:13 AM | David Malcom RodmanChief Medical Officer | Sale | 2,170 | $27.38 | $59.4K | 76,140(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Feb 14 12:25 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 7,707 | $14.25 | 100,001(D) | View → |
| Feb 12, 2026 | Feb 14 12:25 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 6,349 | $1.08 | 31,743(D) | View → |
| Feb 9, 2026 | Feb 11 11:58 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 2,171 | $16.00 | 26,047(D) | View → |
| Jan 20, 2026 | Jan 21 1:33 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 416 | $15.44 | 5,834(D) | View → |
← Previous
Page 3 of 3